Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDXK | O00764 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28464701 | 0.81 | PDXK (0.39) | PDXKKDM4EL3MBTL1PARP1 | |
| SCHEMBL11456047 | 0.81 | PDXK (0.38) | PDXKKDM4EL3MBTL1PARP1 | |
| SCHEMBL19792099 | 0.79 | NOS3 (0.36) | KDM4EL3MBTL1PARP1 | |
| SCHEMBL19622314 | 0.74 | PDXK (0.37) | PDXK | |
| SCHEMBL21508909 | 0.69 | KDM4E (0.37) | PDXKKDM4EL3MBTL1 | |
| SCHEMBL3972895 | 0.67 | TRPA1 (0.41) | KDM4EL3MBTL1 | |
| SCHEMBL9797570 | 0.66 | PDXK (0.44) | PDXK | |
| SCHEMBL18899112 | 0.66 | PDXK (0.32) | PDXK | |
| SCHEMBL15007 | 0.65 | KDM4E (0.61) | KDM4EL3MBTL1 | |
| SCHEMBL18123545 | 0.65 | KCNH2 (0.39) | KDM4EL3MBTL1PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5446102-A | Decreasing molecular weight of unsaturated polymers | BRIDGESTON, CORPORATION (JP) | 1995-08-29 | — | — | US | disclosed |
| US-4072807-A | OLEFIN DISPROPORTIONATION CATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1978-02-07 | — | — | US | disclosed |
| US-3995095-A | Modification of polymers by treatment with olefins | PHILLIPS PETROLEUM COMPANY (US) | 1976-11-30 | — | — | US | disclosed |